NCT06055816 2023-09-28
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Recruiting
Clinical Trials
11 trialsNCT02237924 2022-02-14
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT05177237 2022-01-04
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital
Phase 2 Unknown
NCT02636231 2021-02-03
Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT03989830 2020-10-23
SLICER
Peking University
Phase 2 Unknown
NCT02444949 2020-06-24
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Completed
NCT03932266 2019-04-30
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT02902432 2019-01-31
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
Phase 2 Unknown
NCT02590133 2017-12-22
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Sun Yat-sen University
Phase 2 Unknown
NCT02907710 2016-09-20
Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 3 Unknown
NCT01612286 2014-02-19
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown